Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow
Precision BioSciences, Inc. provided updates on its PBG and HBV programs during a recent presentation. The company also discussed the results of the ELIMINATE-B trial. This information was shared through a slide deck published in conjunction with the event.
- ▪Precision BioSciences, Inc. is listed under the ticker symbol DTIL.
- ▪The company presented updates on its PBG and HBV programs.
- ▪Results from the ELIMINATE-B trial were also discussed.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909249-precision-biosciences-inc-dtil-discusses-updates-on-pbg-and-hbv-program-and-eliminate-b-trial"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
